CLASS II Drug recall · Reported 7 Nov 2018 · FDA Enforcement Report

Catapres .2 (clonidine hydrochloride, USP) 0.2mg recalled

Boehringer Ingelheim Pharmaceuticals is recalling Catapres .2 (clonidine hydrochloride, USP) 0.2mg, distributed nationwide in the US. The recall was initiated on 22 Oct 2018 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot: 757739, EXP 9/2020
Quantity recalled1,380 100-count bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0128-2019
FDA event ID
81340
Recalling firm
Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT
Classification
Class II
Status
Terminated
Recall initiated
22 Oct 2018
FDA classified
1 Nov 2018
Reported
7 Nov 2018
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Potency & Assay

Timeline

22 Oct 2018Recall initiated by company
1 Nov 2018Classified by FDA+10 days
7 Nov 2018Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Dissolution Specifications: OOS resultsduring routine stability testing

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Catapres .2 (clonidine hydrochloride, USP) 0.2mg, 100-count bottles, Rx only, Dist. by: Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT 06877 USA. Made in Germany. NDC 0597-0007-01

Where it was distributed

Distributed nationwide in the USA and Puerto Rico

Nationwide Puerto Rico

Questions about this recall

Why was it recalled?

Failed Dissolution Specifications: OOS resultsduring routine stability testing

Which lots are affected?

Lot: 757739, EXP 9/2020

Where was it sold?

Distributed nationwide in the USA and Puerto Rico

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Boehringer Ingelheim Pharmaceuticals

All 13